Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Small-molecule HCV therapeutics sought in Enanta-Chiron collaboration

Oct. 7, 2002

Novel inhibitors of HCV NS3 protease in BMS pipeline

Oct. 4, 2002

InterMune and Array BioPharma collaborate on hepatitis drug discovery

Oct. 2, 2002

Clinical efficacy and safety of ACH-126443 in HBV demonstrated in phase I/II clinical trial

Oct. 2, 2002

Efficacy of IS-741 on spontaneous colitis in transgenic rat model

Oct. 2, 2002

PARP inhibitor GPI-6150 effective in rat model of colitis

Oct. 2, 2002

Tanabe AAI signs development and licensing agreements for first three compounds

Sep. 30, 2002

Patient enrollment completed in phase IIb renzapride trial in IBS

Sep. 26, 2002

Functional fatty acid compound tested in patients with NASH in U.S. trial

Sep. 26, 2002

First nucleotide analogue for HBV approved by FDA

Sep. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...